Related Experiment Video
Updated: Aug 11, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
The Relationship between 10 Years Risk of Cardiovascular Disease and Schizophrenia Symptoms: Preliminary Results
Esin Evren Kilicaslan1, Merve Karakilic1, Almila Erol1
1Department of Psychiatry, Atatürk Education and Training Hospital, Izmir Katip Celebi University, Izmir, Turkey.
Insights
Patients with schizophrenia have a higher risk of cardiovascular disease, linked to illness duration and antipsychotic use. This study investigated the connection between heart disease risk and schizophrenia symptoms.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Schizophrenia patients face elevated cardiovascular disease (CVD) risk compared to the general population.
- Factors contributing to this risk include antipsychotic medications, genetic predispositions, and lifestyle choices.
- Understanding the interplay between schizophrenia and CVD is crucial for patient management.
Purpose of the Study:
- To investigate the relationship between cardiovascular disease risk and schizophrenia symptomatology.
- To assess 10-year cardiovascular risk using the Framingham Risk Score (FRS) in schizophrenia patients and healthy controls.
Main Methods:
- The Framingham Risk Score (FRS) was calculated for 103 schizophrenia patients and 39 controls.
- Data collected included sociodemographics, illness onset/duration, hospitalizations, and antipsychotic use.
- Symptom severity was assessed using the Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS), and Calgary Depression Scale for Schizophrenia (CDSS).
Main Results:
- Schizophrenia patients exhibited a significantly higher 10-year cardiovascular risk (5.16%) than controls (3.02%).
- FRS scores correlated significantly with age, number of hospitalizations, and illness duration.
- Patients on multiple antipsychotics showed higher FRS scores and lower high-density lipoprotein (HDL) levels.
Conclusions:
- Cardiovascular disease risk in schizophrenia is associated with illness duration and overall severity.
- Antipsychotic medication use, particularly multiple agents, plays a role in elevated cardiovascular risk.
- Further research is needed to mitigate CVD risk in schizophrenia patients.
Objective:
Previous research shows that patients with schizophrenia have increased cardiovascular disease risk than general population. Increased cardiovascular risk in schizophrenia patients have been associated with many reasons such as antipsychotic drugs, genetic predisposition, andlifestyle. In this study, we aimed to investigate the relationship between the risk of heart disease and schizophrenia symptomatology.
Methods:
The 10-year cardiovascular risk was assessed by the Framingham Risk Score (FRS) in 103 patients with schizophrenia and in 39 healthy controls. Sociodemographic characteristics, age at schizophrenia onset, duration of illness, number of hospitalizations, the course of the disease and antipsychotic medications were recorded. Patients' symptoms were evaluated via The Scale for the Assessment of Negative Symptoms (SANS), The Scale for the Assessment of Positive Symptoms (SAPS), and Calgary Depression Scale for Schizophrenia (CDSS).
Results:
Ten-year cardiovascular risk was 5.16% inpatients with schizophrenia, and 3.02% in control group (p=0.030). No significant correlation was found between FRS scores, SANS, SAPS, and CDSS scores. However, FRS scores were significantly correlated with age, number of hospitalizations and duration of disease (r=0.300, 0.261, 0.252, respectively). Moreover FRS scores were higher (p=0.008) and high-density lipoprotein (HDL) levels were lower (p=0.048) in patients using multiple antipsychotics.
Conclusion:
Our findings suggest a relationship between the risk of cardiovascular disease and the duration and overall severity of schizophrenia and also highlights the role of antipsychotics in this relationship.
More Related Videos
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
08:04Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
Published on: November 19, 2020
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Schizophrenia
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia